Editorial on “Albumin-to-fibrinogen ratio as a prognostic biomarker to predict clinical outcome of non-small cell lung cancer individuals”

As shown in “Albumin-to-fibrinogen ratio as a prognostic biomarker to predict clinical outcome of non-small cell lung cancer individuals”, by Li et al., the albumin/fibrinogen ratio (AFR) is a valuable addition to the tools used to assess systemic inflammatory response (SIR) and/or nutrition status in patients with cancer and other serious diseases.